J&J in talks to reduce $1.5 bln Elan deal price: source

BOSTON/NEW YORK (Reuters) – U.S. health-care firm Johnson & Johnson is in talks to cut the price of a $1.5 billion deal with Irish drugmaker Elan Corp , a source familiar with the negotiations said on Sunday.

Leave a Reply